Central Nervous System Drugs Market Competitive Insights, Opportunities & Strategies, Latest Trends, Key Driving Factors And Top Players - Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

According to The Business Research Company's central nervous system drugs market report, the global central nervous system drugs market reached a value of nearly $125,277.9 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.6% since 2015. The market is expected to grow from $125,277.9 million in 2020 to $163,045.4 million in 2025 at a rate of 5.4%. The growth is mainly due to the increasing prevalence of psychological disorders which is expected to drive the demand for central nervous system drugs. The central nervous system (CNS) drugs market is expected to grow from $163,045.4 million in 2025 to $210,912.9 million in 2030 at a CAGR of 5.3%.

The market in the forecast period is expected to be supported by growing government for mental health awareness. While developing countries such as countries in North America and Western Europe already had a reasonable understanding and access to mental healthcare, and thus anti-depressants, this demand has increased multifold owing to the pandemic. For instance, the UK's government launched a Mental Health Recovery Action Plan on March 2021. The government is expected to spend £500 million to support people suffering from severe mental illnesses, including depression and PTSD, and those impacted by the pandemic. Countries such as Australia also invested about $2.3 billion for National Mental Health and Suicide Prevention Plan during the pandemic. This includes funds for increase in treatment for mental health diseases and adding up to 57 mental health treatment sites for adults, thus supporting the growth of the market.

View Our Buying Options For The Central Nervous System Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5332

The central nervous system drugs market is segmented -
• By Type: Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs

• By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies/ Drug Stores

• By Route Of Administration: Oral, Intravenous, Intranasal/ Inhalation

• By Drug Classification: Branded Drugs, Generic Drugs

• By Mode Of Purchase: Over-The-Counter Drugs, Prescription-Based Drugs

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the global central nervous system drugs market.

Major competitors in the central nervous system drugs market include Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Novartis AG, UCB.

See The Full Central Nervous System Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The CNS drugs include anesthetics, anticonvulsants, antiemetics, antiparkinsonian agents, CNS stimulants, analgesics, and sedatives. Neurological diseases such as Epilepsy, Parkinson and psychological indications such as depression, and dementia are generally treated through these CNS drugs.

The Table Of Content For The Central Nervous System Drugs Market Include:

1. Central Nervous System Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
7. Central Nervous System Drugs Market Characteristics
……
26. Global Central Nervous System Drugs Market Competitive Landscape
27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
28. Market Background: Pharmaceutical Drugs Market
29. Central Nervous System Drugs Market Future Outlook and Potential Analysis
30. Appendix

The Business Research Company's "Global Central Nervous System Drugs Opportunities And Strategies Market Report - Forecast To 2030" is the most comprehensive report available in market, providing data and statistics from over 60 geographies analyzed in more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. Additionally, it evaluates the market's historic and projected growth and identifies significant trends and strategies that can be used to outperform the competitors in the sector.

Contact us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Interested to know more about The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.